Eosinophilic Granulomatosis with Polyangiitis: Symptoms, Causes, Diagnosis and Treatment

Written by Medicover Team and Medically Reviewed by Dr Bhavana Surapareddy , Rheumatologists

Eosinophilic Granulomatosis with Polyangiitis (EGPA), formerly known as Churg-Strauss Syndrome, is a rare autoimmune vasculitis that causes inflammation of small- and medium-sized blood vessels. The condition is characterized by asthma, high levels of eosinophils (eosinophilia), and eosinophilic inflammation, which can damage the lungs, skin, nerves, heart, kidneys, and gastrointestinal tract. Symptoms vary widely but often include severe asthma, sinusitis, skin rashes, numbness or weakness, and fatigue. Early diagnosis and prompt treatment with corticosteroids and immunosuppressive or biologic therapies are essential to control inflammation, prevent organ damage, and improve long-term outcomes.

What are the Symptoms of Eosinophilic Granulomatosis with Polyangiitis?

The symptoms of EGPA can vary widely among individuals and may develop gradually over time. They typically progress through three stages: allergic, eosinophilic, and vasculitic.

Allergic Stage

The allergic stage often presents with asthma and allergic rhinitis. Asthma is a predominant feature in EGPA, and its severity can vary. Some individuals may experience frequent asthma attacks, while others may have well-controlled symptoms.

Eosinophilic Stage

During the eosinophilic stage, there is a marked increase in eosinophils, leading to tissue infiltration and damage. Common symptoms include fever, weight loss, fatigue, and pulmonary infiltrates, which may mimic pneumonia.

Vasculitic Stage

The vasculitic stage is characterized by inflammation of blood vessels, which leads to organ damage. Depending on the organs affected, this can manifest in a myriad of symptoms, including skin rashes, neuropathy, abdominal pain, and renal involvement.

What are the Causes of Eosinophilic Granulomatosis With Polyangiitis?

The precise etiology of Eosinophilic Granulomatosis with Polyangiitis remains elusive. However, it is generally accepted that EGPA results from a combination of genetic predisposition and environmental factors that trigger an abnormal immune response.

Genetic and Environmental Factors

While no single genetic marker has been definitively linked to EGPA, specific genetic variants associated with immune system regulation may increase susceptibility. Additionally, environmental factors such as allergens or infections may act as catalysts, prompting the immune system to attack the body's blood vessels and tissues.

The Role of Eosinophils

Eosinophils, a type of white blood cell, play a crucial role in the pathogenesis of EGPA. These cells typically respond to allergens and infections, but in EGPA, they accumulate in tissues, causing inflammation and damage. The presence of high eosinophilia is a hallmark of the condition, often preceding the onset of vasculitis.

When to See a Doctor for Eosinophilic Granulomatosis with Polyangiitis?

Individuals with asthma accompanied by unexplained weight loss, persistent fever, skin rash, nerve problems, or symptoms affecting multiple organs should consult a Rheumatologist or Pulmonologist promptly.

You should see a doctor if you experience:

Seek emergency medical attention immediately if you:

These symptoms may indicate life-threatening organ involvement requiring urgent medical treatment.

Find Rheumatologists for Eosinophilic Granulomatosis With Polyangiitis Treatment Near You

How Is Eosinophilic Granulomatosis with Polyangiitis Diagnosed?

Diagnosing EGPA can be challenging due to its overlapping symptoms with other conditions. A thorough clinical evaluation, along with laboratory and imaging tests, is essential for accurate diagnosis.

Laboratory Tests

Blood tests revealing elevated eosinophil counts are a critical component in diagnosing EGPA. Additionally, the presence of anti-neutrophil cytoplasmic antibodies (ANCA) can support the diagnosis, although not all patients with EGPA are ANCA-positive.

Imaging Studies

Imaging studies, such as chest X-rays and computed tomography (CT) scans, can identify pulmonary infiltrates and other organ involvement. Magnetic resonance imaging (MRI) may be employed to assess neurological complications.

Biopsy

In some cases, a tissue biopsy may be necessary to confirm vasculitis and eosinophilic infiltration. A biopsy can provide definitive histological evidence of EGPA, mainly when blood tests and imaging studies are inconclusive.

What are the Treatment Options for Eosinophilic Granulomatosis with Polyangiitis?

Treatment aims to suppress the immune system, reduce eosinophilic inflammation, prevent organ damage, and maintain long-term remission. Therapy is individualized according to disease severity and organ involvement.

Most individuals require long-term follow-up and adjustment of medications to prevent relapses.

Medical Treatment

Supportive Treatment

Your health is everything - prioritize your well-being today.

Consult Eosinophilic Granulomatosis With Polyangiitis Doctors Today

What is the Recovery Process for Eosinophilic Granulomatosis with Polyangiitis?

EGPA is a chronic condition that often requires lifelong monitoring. Many individuals achieve remission with appropriate treatment, although relapses may occur. Regular follow-up and adherence to treatment help preserve organ function, reduce complications, and improve quality of life.

Taking medications as prescribed, attending regular rheumatology and pulmonology follow-up appointments, monitoring asthma and organ-related symptoms, maintaining a healthy lifestyle, avoiding smoking, and seeking prompt medical attention for new or worsening symptoms help support long-term disease control and recovery.

Recovery Includes